摘要
目的:观察丹红注射液与丹参注射液治疗冠心病的临床疗效,探讨丹红注射液治疗冠心病的临床价值及优越性。方法:将2008年6月至2012年6月在我院收治的106例冠心病患者随机分为丹红组合丹参组各53例,两组患者均给予常规治疗,丹红组加用丹红注射液静脉滴注治疗,丹参组加用丹参注射液静脉滴注治疗,观察两组患者临床疗效。结果:丹红组总有效率为96.23%,明显高于丹参组的79.25%(P<0.05);丹红组治疗后NST数明显低于对照组(P<0.05);两组不良反应均较轻微,且发生率比较无显著差异(P>0.05)。结论:丹红注射液治疗冠心病具有疗效好、不良反应少等优点,值得临床推广应用。
Objective： To observe the clinical efficacy of Danhong injection and Danshen injection on the treatment of coronary heart disease, and investigate the clinical values and superiority of Danhong injec- tion on the treatment of coronary disease. Method： 106 cases of coronary heart disease are randomly divided into the Danhong group and the Danshen group （each with 53 cases） who were treated in the hospital from June 2008 to June 2012. Both groups were treated with conventional therapy. The Danhong group was addi- tionally treated with intravenous drip of Danhong injection, while the Danshen group was additionally treated with intravenous drip of Danshen injection. The clinical efficacy of both groups is observed. Result： The ORR of the Danhong group was 96.23%, significantly higher than 79.25% of the Danshen group （ P〈O. 05 ）. After treatment, The NST number of the Danhong group was significantly lower than that of the control group （ P〈0.05 ）. The adverse reactions of both groups were slight and there was no significant difference in incurrence （P〉0.05）. Conclusion： With good curative effects and few adverse reactions, Danhong injec- tion is well worth application in the treatment of coronary heart disease.
出处
《河北医学》
CAS
2013年第7期983-985,共3页
Hebei Medicine
关键词
丹红注射液
丹参注射液
冠心病
心电图
Danhong injection
Danshen injection
Coronary heart disease
ECG
